When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
APTO - FDA accepts Aptose's IND for CG-806; shares up 10% premarket
Aptose Biosciences Inc.
The FDA has completed the review of Aptose Biosciences' (NASDAQ:APTO) IND submission for CG-806. The Company has been granted IND allowance to initiate Phase 1 trial with expansions to assess the safety, tolerability, PK, and preliminary efficacy of CG-806 in patients with chronic lymphocytic leukemia (CLL/SLL) or non-Hodgkin lymphomas (NHL).
More news on: Aptose Biosciences Inc., Healthcare stocks news, Stocks on the move,